Like what you read? Get new posts delivered straight to your inbox!
Contact Us | Follow Us
Experience. Integrity. IMPACT.
What We Do

Jeff Golden Promoted to Senior Director, Regulatory Services

RESEARCH TRIANGLE PARK, NC: January 10, 2022 – In October 2021, Jeff Golden, was promoted to the position of Senior Director, Regulatory Services at Impact Pharmaceutical Services, Inc. (IMPACT).

Since joining IMPACT in 2016, Jeff has been a driving force in shaping the direction and growth of the Regulatory Services Department at IMPACT.  Jeff has also contributed significantly to the overall success of the company as a key member of Impact’s Leadership Team.  Under Jeff’s leadership, IMPACT’s Regulatory Services Department has more than doubled in size and provided regulatory publishing and electronic submission services to over 50 different biopharmaceutical companies in the United States and around the world.  In 2021, Jeff hired the company’s first Regulatory Affairs Managers, significantly expanding the regulatory service offering that IMPACT can provide to its clients.

Jeff came to IMPACT with over 15 years of experience in pharmaceutical regulatory affairs. He began his career at Fujisawa (later Astellas Pharma US) where he worked in the central document room preparing documents for electronic submission and archiving. He then joined TAP Pharmaceuticals (joint venture of Abbott Laboratories and Takeda Pharmaceuticals; later Takeda Pharmaceuticals) where he served as a publisher on the company’s first NDA in eCTD format for Uloric® and managed the publishing and submission management activities to approval for some of the company’s priority programs, such as KAPIDEX™ and the Alogliptin family of products.  Following his years at Takeda, Jeff took a position as head of Regulatory Operations at Chimerix, Inc., where he managed the day-to-day submissions and project planning activities for their development programs and marketing applications.

Mark Cierpial, CEO and Vice President of Regulatory Services, comments, “Jeff’s depth of knowledge in regulatory affairs, as well as his leadership skills and problem-solving acumen, have made him an incredible asset to Impact over the past 5 years.  I can’t wait to see what the coming years will bring!”

IMPACT is a Contract Research Organization (CRO) located in Research Triangle Park, NC. Our team consists of drug development professionals who specialize in medical writing and quality control, drug development consulting, regulatory affairs, regulatory operations, and project and program management.

Media Contact:

Mark A. Cierpial, PhD, Chief Executive Officer
Phone: (919) 899-9248
Fax: (919) 354-6090
mcierpial@impactpharma.com
www.impactpharma.com

6